Added to YB: 2022-07-14
Pitch date: 2022-07-14
NVAX [bearish]
Novavax, Inc.
+81.29%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally.
Market Cap
$1.6B
Pitch Price
$52.05
Price Target
N/A
Dividend
N/A
EV/EBITDA
16.26
P/E
-18.02
EV/Sales
1.86
Sector
Biotechnology
Category
N/A
Show full summary:
NOVAVAX INC NVAX
A summary for this pitch has not been created yet.
Read full article (0 min)